Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn

New England Journal of Medicine

Volumn 342, Issue 7, 2000, Pages 469-474

  Clark, Reese H ^a,j   Kueser, Thomas J ^b   Walker, Marshall W ^c   Southgate, W Michael ^d   Huckaby, Jeryl L ^e   Perez, Jose A ^f   Roy, Beverly J ^g   Keszler, Martin ^h   Kinsella, John P ⁱ  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c GREENVILLE HOSPITAL SYSTEM   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e Children's Healthcare of Atlanta at Egleston   (United States)

^f ARNOLD PALMER HOSPITAL FOR CHILDREN   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GEORGETOWN UNIVERSITY HOSPITAL   (United States)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j PEDIATRIX MEDICAL GROUP   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TISSUE OXYGENATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; CHRONIC DISEASE; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; INFANT, NEWBORN; LUNG DISEASES; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SINGLE-BLIND METHOD;

EID: 0034677445     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200002173420704     Document Type: Article

References (33)

1. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995;126:853-64.
2. Morin FC III, Stenmark KR. Persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 1995;151:2010-32.
3. Cornish JD, Heiss KF, Clark RH, Strieper MJ, Boecler B, Kesser K. Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. J Pediatr 1993;122:105-9.
4. Kanto WP, Bunyapen C. Extracorporeal membrane oxygenation: controversies in selection of patients and management. Clin Perinatol 1998;25: 123-35.
5. Kanto WP Jr. A decade of experience with neonatal extracorporeal membrane oxygenation. J Pediatr 1994;124:335-47.
6. UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348: 75-82.
7. Idem. The Collaborative UK ECMO trial: follow-up to 1 year of age. Pediatrics 1998;101:690. abstract.
8. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989;84:957-63.
9. Glass P, Wagner AE, Papero PH, et al. Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 1995;127:447-57.
10. Glass P, Bulas DI, Wagner AE, et al. Severity of brain injury following neonatal extracorporeal membrane oxygenation and outcome at age 5 years. Dev Med Child Neurol 1997;39:441-8.
11. Vaucher YE, Dudell GG, Bejar R, Gist K. Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. J Pediatr 1996;128:109-17.
12. Walsh-Sukys MC, Bauer RE, Cornell DJ, Friedman HG, Stork EK, Hack M. Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes. J Pediatr 1994;125:104-10.
13. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990;259:H1921-H1927.
14. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol 1992;263:H875-H880.
15. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
16. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
17. Steinhorn RH, Morin FC III, Fineman JR. Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation. Semin Perinatol 1997;21:393-408.
18. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
19. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998;101:325-34.
20. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604. [Erratum, N Engl J Med 1997;337: 434.]
21. Idem. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997;99:838-45.
22. Wessel DL, Adatia I, Van Marter LJ, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1997;100:888. abstract.
23. Gaston B, Keith JF III. Nitric oxide and bleeding time. Pediatrics 1994;94:134-5.
24. George TN, Johnson KJ, Bates JN, Segar JL. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998;132:721-4.
25. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994;151:125-9.
26. Freeman BA, Panus PC, Matalon S, Buckley BJ, Baker RR. Oxidant injury to the alveolar epithelium: biochemical and pharmacologic studies. Res Rep Health Eff Inst 1993;54:1-3.
27. Freeman B. Free radical chemistry of nitric oxide: looking at the dark side. Chest 1994;105:Suppl:79S-84S.
28. Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med 1996;21:43-52.
29. Luperchio S, Tamir S, Tannenbaum SR. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic Biol Med 1996;21:513-9.
30. Hallman M, Bry K. Nitric oxide and lung surfactant. Semin Perinatol 1996;20:173-85.
31. Guidot DM, Repine MJ, Hybertson BM, Repine JE. Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. Am J Physiol 1995;269:L2-L5.
32. Guidot DM, Hybertson BM, Kitlowski RP, Repine JE. Inhaled NO prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am J Physiol 1996;271:L225-L229.
33. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997;41:457-63.